Investigating the impact of adiposity-redox defence interaction on redox homeostasis and inflammatory and cancer-related pathways in human colonocytes Mar 15, 2021 - Mar 14, 2023
Colorectal cancer is the third most common cancer and the second most common cause of cancer-related death.
Increased body fat have been reported as one of the main factors responsible for the rise in colorectal cancer.
For this reaso...
Read More about Investigating the impact of adiposity-redox defence interaction on redox homeostasis and inflammatory and cancer-related pathways in human colonocytes.
All Projects (65)
Dial a wavelength for exploiting the algal cell factory Oct 1, 2021 - Sep 30, 2025
This project aims to develop a new solution for cost effective production of microalgae, using efficient smart lighting that can adapt both intensity and wavelength during a growth cycle to target strains and specific products.
Development and characterisation of novel polymer-drug conjugates for the treatment of Alzheimer’s disease Sep 1, 2022 - Aug 31, 2024
Using new polymer-drug compounds to improve the ability to deliver anti-Alzheimer drugs in the body.
LACS Thermal Investigations for Battery Applications Aug 1, 2022 - Oct 7, 2022
The aim of the project is to investigate the effect that charge / discharge cycles have have on a battery pack. A map distribution of the registered temperature over each charge / discharge cycle will be monitored and all values recorded using a temp...
Read More about LACS Thermal Investigations for Battery Applications.
Green hydrogen from brewing biomass Jun 27, 2022 - Jun 26, 2023
Aberdeen has purchased and put into operation the world’s first fleet of double decker buses powered by hydrogen. The local authority’s aim is to advance Aberdeen into a world leading Hydrogen City and to develop Scotland’s first commercially scalabl...
Read More about Green hydrogen from brewing biomass.
Mitigating Microbial Hazards - Eliminating HABs Sep 1, 2023 - Aug 31, 2026
Harmful algal blooms (HABs) can cause significant loss of farmed salmon particularly through gill damage and oxygen depletion. While there have been significant advances it has still proved difficult to protect caged salmon. Advanced oxidative meth...
Read More about Mitigating Microbial Hazards - Eliminating HABs.
Valorisation of algal biomass Mar 1, 2023 - Feb 29, 2024
ScotBio uses novel biotech approaches to manufacture natural pigments and vegan proteins from microalgae with applications in food, cosmetics, textiles and pharmaceuticals. The microalgae make this pigment as well as many other bioactive compounds us...
Read More about Valorisation of algal biomass.
Nationwide surveillance of antimicrobial resistance in the Scottish population by wastewater-based epidemiology Oct 1, 2023 - Sep 30, 2027
Antimicrobial resistance (AMR) is one of the most significant threats to global health we face today. The WHO outlined in their AMR Global Action Plan that surveillance of AMR is essential to strengthen our knowledge and evidence base, and for the de...
Read More about Nationwide surveillance of antimicrobial resistance in the Scottish population by wastewater-based epidemiology.
A novel in vitro model of the human intestinal epithelium in co-culture with “gut-like” dendritic cells Feb 1, 2023 - Dec 31, 2024
In the UK, over half a million people have an Inflammatory Bowel Disease, like Crohn’s disease or ulcerative colitis. These diseases cause painful symptoms like severe pain, diarrhoea, and weight loss. This is due to the body's immune system attackin...
Read More about A novel in vitro model of the human intestinal epithelium in co-culture with “gut-like” dendritic cells.
Novel titanium oxide-graphene electrodes for the generation of green hydrogen from brewing biomass May 1, 2023 - Sep 15, 2023
A knowledge exchange platform between RGU and the Muroran Institute of Technology, Japan.
This will inform the generation of a novel electrode, compatible with the electrochemical cell developed at RGU, which is not commercially avail...
Read More about Novel titanium oxide-graphene electrodes for the generation of green hydrogen from brewing biomass.
Rapid, quantitative field test for shellfish toxins May 1, 2023 - Jan 31, 2025
Aquaculture in the UK is essential for food security, and production is expected to double in the next two decades. The shellfish industry employs >3,000 people with a revenue in excess of £40 million per annum. One of the challenges to this industry...
Read More about Rapid, quantitative field test for shellfish toxins.
Multi-time Scale State-of-Health Assessment Research of Lithium-ion Batteries Apr 1, 2023 - Mar 31, 2024
Identify through modelling the state of health of lithium ion batteries
With the continuous development of new energy vehicles, large-scale energy storage, special robots, and aerospace equipment, the demand for battery systems continu...
Read More about Multi-time Scale State-of-Health Assessment Research of Lithium-ion Batteries.
Cannabidiol and CBD oil for prevention of cardiac dysfunction Mar 9, 2023 - Mar 8, 2024
Cannabidiol (CBD) has cardioprotective properties against the outcome of myocardial ischaemia and reperfusion. CBD oil, which contains not only cannabidiol but a host of biologically active molecules that may also offer some benefits to cardiac heal...
Read More about Cannabidiol and CBD oil for prevention of cardiac dysfunction.
Valorisation of biomass from seed potatoes production Jun 12, 2023 - May 30, 2024
In the potato industry, over 800 thousand tons of dry foliage are produced, which could be turned into high value chemicals/products across many industries. The cooperative is looking for new value chains and to add value to the by-product from their...
Read More about Valorisation of biomass from seed potatoes production.
Multitargets drug for Sepsis: Mechanistic studies of drug action through mitigating infection and inflammatory responses associated with sepsis. Oct 1, 2023 - Sep 30, 2025
Sepsis is a life-threatening clinical condition caused by an overreacting immune system fighting an infection. It is often treated with broad-spectrum antibiotics together with anti-inflammatory drugs. However, due to the heterogeneous nature of the...
Read More about Multitargets drug for Sepsis: Mechanistic studies of drug action through mitigating infection and inflammatory responses associated with sepsis..
Unlocking the biotechnological potential of Desertfilium tharense Aug 1, 2023 - Jul 31, 2024
Cyanobacteria, often known as blue-green algae, are an essential component of global ecosystems using light and carbon dioxide to produce organic carbon and oxygen. Consequently, they are found in diverse habitats including terrestrial and aquatic ha...
Read More about Unlocking the biotechnological potential of Desertfilium tharense.
One Health Prescribing – New Analytical Methods to Inform Formulary Changes to Chiral Pharmaceuticals for Environmentally Friendlier Medicines Oct 1, 2023 - Sep 30, 2027
There is a need to reduce pollutants at source instead of relying on water treatment for their removal. The One Health Breakthrough Partnership is working to reduce pharmaceutical pollution entering the environment. This includes prescribing medicine...
Read More about One Health Prescribing – New Analytical Methods to Inform Formulary Changes to Chiral Pharmaceuticals for Environmentally Friendlier Medicines.
Synthesis of substituted triazines and their investigation as corrosion inhibitors on mild steel and aluminium in corrosive environments Aug 1, 2023 - Dec 1, 2023
The serious consequences of the corrosion process have become a problem of worldwide significance - corrosion is the destructive attack of a material by reacting to its environment. Corrosion causes plant shutdowns, wastes valuable resources, causes...
Read More about Synthesis of substituted triazines and their investigation as corrosion inhibitors on mild steel and aluminium in corrosive environments.
The role of Glutathione Peroxidase 4 (GPX4) and the GPX4 single-nucleotide polymorphism (SNP), rs713041, in metabolic syndrome associated vascular dysfunction Sep 1, 2023 - Feb 28, 2025
High blood sugar, high blood pressure, and obesity are all features of the ‘umbrella term’ metabolic syndrome (MetS) which affects 1 in 3 people over 50 years old in the UK. MetS increases the risk of developing heart disease and in particular the co...
Read More about The role of Glutathione Peroxidase 4 (GPX4) and the GPX4 single-nucleotide polymorphism (SNP), rs713041, in metabolic syndrome associated vascular dysfunction.
Exploring the anti-atherogenic properties of a compound derived from Amaryllidaceae (Daffodil) Sep 1, 2023 - Apr 30, 2024
Agroceutical Products Ltd (APL) produces sustainable quantities of the naturally derived alkaloid galanthamine from daffodils, which is a key active pharmaceutical used for the treatment of Alzheimer’s disease. Daffodils contain an abundance of other...
Read More about Exploring the anti-atherogenic properties of a compound derived from Amaryllidaceae (Daffodil).